Pharmaceutical - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

201 to 225 of 420 results

Tafinlar now approved for metastatic melanoma in Europe

02-09-2013

UK pharma giant GlaxoSmithKline's (LSE: GSK) Tafinlar (dabrafenib) has been cleared for marketing by…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationTafinlar

ChemoCentryx plunges as partnered drug candidate fails to meet endpoints

26-08-2013

US drug developer ChemoCentryx (Nasdaq: CCXI) saw its shares plummet 31.6% to $7.99 last Friday (August…

ChemoCentryxGastro-intestinalsGlaxoSmithKlinePharmaceuticalResearch

New Zealand proposals for influenza vaccines

21-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

GSK's Flulaval vaccine approved by US FDA

16-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has had its Flulaval quadrivalent intramuscular influenza…

FluarixFlulavalGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

Potential Duchenne drug expected to complete phase III trial this year

16-08-2013

Dutch biotech company Prosensa says it has made progress with its Duchenne treatments, with six exon…

drisapersenEuropeGeneticsGlaxoSmithKlinePharmaceuticalProsensaResearch

GSK's breast cancer drug Tyverb gets EU marketing authorization for extra indication

15-08-2013

UK pharma major GlaxoSmithKline (LSE: GSK) has received marketing authorization from the European Commission…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationTyverb

FDA approves new ViiV Healthcare HIV drug

13-08-2013

The US Food and Drug Administration yesterday (August 12) approved Tivicay (dolutegravir), a new drug…

Anti-viralsdolutegravirGlaxoSmithKlineNorth AmericaPfizerPharmaceuticalRegulationShionogiTivicayViiV Healthcare

EU5 rheumatologits rate Rituxan and Benlysta for Lupus

12-08-2013

Rheumatologists in the top European nations ( EU5) countries (France, Germany, Italy, Spain, UK) give…

Anti-Arthritics/RheumaticsBenlystaBiogen IdecBristol-Myers SquibbEuropeGlaxoSmithKlineMarkets & MarketingOrenciaPharmaceuticalRituxanRoche

GSK launches $50 million VC fund to invest in pioneering bioelectronic medicines and technologies

08-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) today (August 8) announced the launch of Action Potential…

BiotechnologyFinancialGlaxoSmithKlinePharmaceuticalResearchSetPoint Medical

GlaxoSmithKline files for expanded use for Votrient

07-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) says it has submitted a request to the European Medicines…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVotrient

US FDA approves shipment of quadrivalent flu vaccine to health care providers

06-08-2013

The US subsidiary of UK pharma giant GlaxoSmithKline (LSE: GSK) says it has received Food and Drug Administration…

Anti-viralsFluarixGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

US PDUFA for GSK diabetes drug delayed

03-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) revealed on Friday (August 2) that the US Prescription Drug…

albiglutideDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

Slow uptake of HPV vaccine in USA "risks health of next generation"

29-07-2013

US human papillomavirus (HPV) vaccination rates in girls aged 13-17 years failed to increase between…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoNorth AmericaPharmaceuticalVaccines

More details emerge of GSK China bribery allegations

26-07-2013

The extent of the alleged bribery and tax-related violations by UK pharma major GlaxoSmithKline (LSE:…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

GlaxoSmithKline 2nd-qtr sales up 2% but EPS falls 14%

24-07-2013

UK pharma giant GlaxoSmithKline posted second-quarter 2013 financial results showing that turnover increased…

FinancialGlaxoSmithKlinePharmaceutical

GSK's Revolade recommended by UK's NICE for low blood platelet counts

24-07-2013

The UK's drugs watch dog the National Institute for Health and Care Excellence (NICE) has recommended…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRevolade

Investigation on-going as claims GSK staff may have broken Chinese law

22-07-2013

Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

China says GSK probe part of business climate clean-up

17-07-2013

China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates

16-07-2013

Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GlaxoSmithKline and Theravance withdraw Japan NDA for Relvar Ellipta in COPD

12-07-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) revealed on Friday…

Asia-PacificBiotechnologyGlaxoSmithKlinePharmaceuticalRegulationRelvar ElliptaRespiratory and PulmonaryTheravance

201 to 225 of 420 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top